Skip to main content
Clinical Trials/IRCT2014121420306N1
IRCT2014121420306N1
Completed
Phase 2

Determine predictive factors of embryo transfer on day 2 versus day 3on intracytoplasmic sperm injection-embryo transfer cycles clinical outcomes.

Vice chancellor for research, Shahid Beheshti University of Medical Science0 sites300 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice chancellor for research, Shahid Beheshti University of Medical Science
Enrollment
300
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice chancellor for research, Shahid Beheshti University of Medical Science

Eligibility Criteria

Inclusion Criteria

  • women aged 20\-40 years old undergoing fresh intracytoplasmic sperm injection\-embryo transfer cycles; have normal endometrial thickness (7\-12 milimeters) on embryo transfers day; don't have any visible endometrial pathology; do not have more than three failed previous intracytoplasmic sperm injection\-embryo transfer cycles.
  • Exclusion criteria: abnormally shaped uterus in hysterosalpingography or hysteroscopy; have more than 3 previous failure of intracytoplasmic sperm injection\-embryo transfer cycles .

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials